FDA Clamping Down on Abuse of an OTC   Decongestant

THURSDAY, March 25, 2021 -- Makers of inhalers that contain the nasal decongestant propylhexedrine should make design changes to prevent misuse, the U.S. Food and Drug Administration says. Propylhexedrine is a nasal decongestant in over-the-counter...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news